Show simple item record

dc.contributor.authorRead, Gen
dc.contributor.authorJohnston, Ruth Jen
dc.date.accessioned2010-05-25T11:38:57Z
dc.date.available2010-05-25T11:38:57Z
dc.date.issued1993
dc.identifier.citationShort duration radiotherapy in stage I seminoma of the testis: preliminary results of a prospective study. 1993, 5 (6):364-6 Clin Oncol (R Coll Radiol)en
dc.identifier.issn0936-6555
dc.identifier.pmid8305356
dc.identifier.doi10.1016/S0936-6555(05)80087-1
dc.identifier.urihttp://hdl.handle.net/10541/99800
dc.description.abstractNinety-four patients with Stage I seminoma of the testis, treated between November 1989 and December 1991, received short duration radiotherapy (2000 cGy in 8 fractions) to the para-aortic area only. The treatment was well tolerated and, after a median follow-up time of 34 months (minimum 15 months), no patient has relapsed in the abdomen. One patient developed an apparently solitary distant metastasis from a latent teratoma and is disease free after chemotherapy. This form of radiotherapy would appear to be well-tolerated with a low relapse rate. It offers the advantage of a simpler and shorter technique compared with conventional therapy and avoids the necessity of intensive surveillance to detect relapse.
dc.language.isoenen
dc.subjectCancer Stagingen
dc.subjectTesticular Canceren
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshFollow-Up Studies
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshNeoplasm Staging
dc.subject.meshProspective Studies
dc.subject.meshRadiotherapy Dosage
dc.subject.meshSeminoma
dc.subject.meshTesticular Neoplasms
dc.subject.meshTreatment Outcome
dc.titleShort duration radiotherapy in stage I seminoma of the testis: preliminary results of a prospective study.en
dc.typeArticleen
dc.contributor.departmentDepartment of Radiotherapy, Christie Hospital, Manchester, UK.en
dc.identifier.journalClinical Oncologyen
html.description.abstractNinety-four patients with Stage I seminoma of the testis, treated between November 1989 and December 1991, received short duration radiotherapy (2000 cGy in 8 fractions) to the para-aortic area only. The treatment was well tolerated and, after a median follow-up time of 34 months (minimum 15 months), no patient has relapsed in the abdomen. One patient developed an apparently solitary distant metastasis from a latent teratoma and is disease free after chemotherapy. This form of radiotherapy would appear to be well-tolerated with a low relapse rate. It offers the advantage of a simpler and shorter technique compared with conventional therapy and avoids the necessity of intensive surveillance to detect relapse.


Files in this item

This item appears in the following Collection(s)

Show simple item record